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' Background
Alzheimer’s disease (AD), the most common cause of
dementia in the elderly, is characterized by the presence
of Ab plaques, which results in a progressive neuronal
degeneration and subsequent cognitive decline. Den-
drites and axons in the region surrounding the plaques
may become damaged and swollen, forming what are
known as dystrophic neurites (DNs). However, the
mechanisms by which DNs affect cognitive function in
AD patients are not understood.
Methods
While characterizing the reticulon (RTN)/Nogo family of
proteins, which have been shown to negatively regulate
BACE1 activity, we found that RTN3, which is primarily
neuronally expressed, accumulates in a distinct population
of DNs called RTN3 Immunoreactive Dystrophic Neurites
(RIDNs) in the brains of AD patients and in APP trans-
genic mice, an animal model for AD. More importantly,
transgenic mice overexpressing RTN3 (Tg-RTN3) produce
RIDNs in the hippocampus at a young age, while wild-type
mice produce similar RIDNs only at older ages.
Results
The importance of RIDNs in relation to cognitive decline
is further evidenced by the finding that Tg-RTN3 mice
where RIDNs are present show impaired learning and spa-
tial memory, reduced spine density and synaptic plasticity.
Molecular characterization of RIDNs indicates that RIDNs
contain RTN3 aggregates and inducible expression of
RTN3 in a mouse model reveals that RTN3 aggregates are
formed irreversibly.
Conclusion
Together, our results suggest that inhibition of RTN3
aggregation is a promising approach for improving cog-
nitive dysfunction associated with Alzheimer’s
pathology.
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